This observation was further supported by a considerable reduction in the major angiogenesis marker protein, VEGF in tumour sections of DW-F5-treated mice as assessed by IHC (Fig. 7b), corroborating the in vitro results (Fig. 3k). This evidence concerns the gene VEGFA and neoplasm.